Our magazine is free!

for living with diabetes

Articles related to "Novo Nordisk" »

Novo Nordisk UK launches new type 2 diabetes treatment

Friday, April 5th, 2019 | 0 Comments
Novo Nordisk UK has announced that Ozempic (semaglutide), a new once-weekly GLP-1 analogue injection for the treatment of Type 2 diabetes is now available in the UK. Ozempic works by mimicking the function of the GLP-1 (human glucagon-like peptide-1) hormone produced in the read more »

Should we worry about diabetes medicines shortages?

Friday, February 8th, 2019 | 0 Comments
Commenting on news stories about the possibility of medical supplies being jeopardized by the looming decision about Britain leaving the EU, JDRF has affirmed that it is committed to ensuring that the needs of people with Type 1 diabetes are taken into read more »

California stem cell site for Novo Nordisk

Monday, November 26th, 2018 | 0 Comments
Novo Nordisk has announced the establishment of a manufacturing site in Fremont, California, to develop and produce stem cell-based therapies. The announcement follows the signing of a long-term lease on a facility. The site will support the company’s increased commitment to develop read more »

Howzat? ‘Walking Cricket’ sessions improve diabetes health

Monday, November 19th, 2018 | 0 Comments
An 80-year-old man with T2 diabetes has improved his health by attending Walking Cricket sessions, proving it’s never too late to start exercising after taking part in a series of Walking Cricket sessions. Shirish Modi from Leicester found out about the activity and read more »

Novo Nordisk’s Fiasp for use in Insulet’s Omnipod

Wednesday, October 10th, 2018 | 0 Comments
In a report by Sarah Faulkner for Drug Delivery Business, Insulet has announced that its Omnipod insulin management system is available in Europe for use with Novo Nordisk’s Fiasp (fast-acting insulin aspart). Novo Nordisk’s Fiasp product enters the user’s bloodstream two times faster read more »

We’ve come a long way baby! An interview with Professor John Pickup

Friday, September 28th, 2018 | 0 Comments
Emeritus Professor John Pickup Professor John Pickup has been involved in diabetes care for most of his career in medicine. He’s been there from the beginning, when continuous subcutaneous insulin infusion (CSii for short) was in its inception. I talked to him recently read more »

Latest issue: Sophie tells of having her diabetes reclassified, no longer needing insulin; plus all you need to know about coeliac disease and gluten intolerance and diabetes

Wednesday, September 26th, 2018 | 0 Comments
In this issue we look at what you need to know about coeliac disease and gluten intolerance. There’s news (from p.4) about Dexcom buying TypeZero (a diabetes management platform), Novo Nordisk buying Ziylo (developer of glucose binding molecules, leading to the development read more »

Novo Nordisk buys Ziylo, creator of glucose responsive insulins

Monday, September 24th, 2018 | 0 Comments
Dr Harry Destecroix, 31, co-founded Ziylo while studying for his PhD at the University of Bristol four years ago. It created a new technology that can be developed to treat diabetes more effectively. Pharmaceutical giant Novo Nordisk’s purchase means it now has read more »

WORD UP! Living with diabetes in your own words

Saturday, March 3rd, 2018 | 0 Comments
In Your Own Words, Reflections of Living with Diabetes is a book of thoughts complied from people with Type 2 diabetes who were asked to write back to their younger selves in order to share insights and reflect on living with the read more »

NovoPen cartridge holder possible risk of cracking

Friday, July 14th, 2017 | 0 Comments
Novo Nordisk A/S has detected that the insulin cartridge holder used in a number of NovoPen Echo and NovoPen 5 batches may crack or break if exposed to certain chemicals, for example household cleaning agents. Novo Nordisk urges people with diabetes using read more »
""